In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19.

Sanchis-Gomar, Fabian; Lavie, Carl J; Perez-Quilis, Carme; Henry, Brandon M; Lippi, Giuseppe

Sanchis-Gomar, Fabian; Lavie, Carl J; Perez-Quilis, Carme; Henry, Brandon M; Lippi, Giuseppe.

Sanchis-Gomar F; University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana.
Perez-Quilis C; University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
Henry BM; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Lippi G; University of Verona, Verona, Italy.

Mayo Clin Proc ; 95(11): 2561-2563, 2020 11.

Article in English | MEDLINE | ID: covidwho-756848

Subject(s)

Betacoronavirus; COVID-19; Coronavirus Infections; Coronavirus Infections/epidemiology; Humans; Pandemics; Renin-Angiotensin System

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus Infections / Betacoronavirus / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Mayo Clin Proc Year: 2020 Document Type: Article Affiliation country: J.mayocp.2020.09.011

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google